Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression
Clinical trial NCT03050736 · COMPLETED
Trial details
- NCT number
- NCT03050736
- Sponsor
- Kintara Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-17
- Primary completion
- 2021-11-22
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.